Document is current
Any future updates will be listed below
-
Authors
Taniguchi, Sakura Hiraide
Takahashi, Masanobu https://orcid.org/0000-0001-9306-7041
Chiu, Shih-Wei
Komine, Keigo
Wakayama, Shonosuke
Numakura, Ryunosuke
Yoshida, Yuya
Kasahara, Yuki
Ouchi, Kota
Imai, Hiroo
Saijo, Ken
Shirota, Hidekazu
Ishioka, Chikashi
- License Information
-
More Information
Article History
Received: 28 September 2024
Accepted: 4 February 2025
First Online: 28 February 2025
Declarations
:
: Masanobu Takahashi received research funding from Ono Pharmaceutical and honoraria from Daiichi Sankyo Company, Bristol Myers Squibb, and Ono Pharmaceutical. Chikashi Ishioka received research funding from Chugai Pharmaceutical, Taiho Pharmaceutical, Daiichi Sankyo Company, Asahi Kasei Pharma, Bayer Yakuhin, Takeda Pharmaceutical, Ono Pharmaceutical and received honoraria from Chugai Pharmaceutical and Daiichi Sankyo Company, and representatives of the Tohoku Clinical Oncology Research and Education Society, a specified nonprofit corporation. Ken Saijo received research funding from Adlai Norty and Takeda Science Foundation. The other authors declare no conflicts of interest.
